Citation: | GUO Bin, CHEN Rui, WANG Sheng-ying, PENG Mei. Analysis of factors related to cervical lymph node metastasis in 208 patients with papillary thyroid carcinoma[J]. Chinese Journal of General Practice, 2022, 20(2): 195-198, 262. doi: 10.16766/j.cnki.issn.1674-4152.002310 |
[1] |
WANG J, YU F, SHANG Y, et al. Thyroid cancer: Incidence and mortality trends in China, 2005-2015[J]. Endocrine, 2020, 68(1): 163-173. doi: 10.1007/s12020-020-02207-6
|
[2] |
张小鹏, 张俊青, 李晓铷, 等. 2011—2015年合肥市区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(12): 907-912. doi: 10.11735/j.issn.1004-0242.2019.12.A005
|
[3] |
MAO L N, WANG P, LI Z Y, et al. Risk factor analysis for central nodal metastasis in papillary thyroid carcinoma[J]. Oncology letters, 2015, 9(1): 103-107. doi: 10.3892/ol.2014.2667
|
[4] |
HAUGEN B R, ALEXANDER E K, BIBLE K C, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
|
[5] |
AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2): 93-99. doi: 10.3322/caac.21388
|
[6] |
GHARIB H, PAPINI E, GARBER J R, et al. American association of clinical endocrinologists, American college of endocrinology and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update[J]. Endocr Pract, 2016, 22(5): 622-639.
|
[7] |
BACK K, KIM J S, KIM J H, et al. Superior located papillary thyroid microcarcinoma is a risk factor for lateral lymph node metastasis[J]. Ann Surg Oncol, 2019, 26(12): 3992-4001. doi: 10.1245/s10434-019-07587-2
|
[8] |
SHENG L, SHI J, HAN B, et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma[J]. Am J Surg, 2020, 220(2): 334-340. doi: 10.1016/j.amjsurg.2019.11.032
|
[9] |
MA B, WANG Y, YANG S, et al. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis[J]. Int J Surg, 2016, 28: 153-161. doi: 10.1016/j.ijsu.2016.02.093
|
[10] |
王岩岩, 李莉, 彭德峰, 等. 甲状腺微小乳头状癌中央区淋巴结转移的相关因素分析[J]. 中华全科医学, 2018, 16(8): 1268-1270, 1282. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201808014.htm
|
[11] |
GUI C Y, QIU S L, PENG Z H, et al. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study[J]. J Endocrinol Invest, 2018, 41(4): 403-409. doi: 10.1007/s40618-017-0759-y
|
[12] |
KIM S K, WOO J W, PARK I, et al. Computed tomography-detected central lymph node metastasis in ultrasonography node-negative papillary thyroid carcinoma: Is it really significant?[J]. Ann Surg Oncol, 2017, 24(2): 442-449. doi: 10.1245/s10434-016-5552-1
|
[13] |
LIU Y, ZHOU H, YANG P, et al. Contrast-enhanced ultrasonography features of papillary thyroid carcinoma for predicting cervical lymph node metastasis[J]. Exp Ther Med, 2017, 14(5): 4321-4327. http://www.onacademic.com/detail/journal_1000040238785910_8a27.html
|
[14] |
邓水平, 李泉水, 陈胜华, 等. 甲状腺微小乳头状癌的超声特征与颈部淋巴结转移相关因素分析[J]. 临床超声医学杂志, 2017, 19(6): 424-426. doi: 10.3969/j.issn.1008-6978.2017.06.025
|
[15] |
LI R Q, YUAN G H, CHEN M, et al. Evaluation of diagnostic efficiency of ultrasound features on malignant thyroid nodules in Chinese patients[J]. Chin Med J (Engl), 2016, 129(15): 1784-1788. doi: 10.4103/0366-6999.186643
|
[16] |
陈亮, 彭泉, 于华杰, 等. 甲状腺微小乳头状癌中央区淋巴结转移的危险因素分析[J]. 中国现代普通外科进展, 2019, 22(10): 818-820. https://www.cnki.com.cn/Article/CJFDTOTAL-PWJZ201910020.htm
|